Purchases and Sales Made in Q3 2023 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q3 2023. The information is specifically focused on institutions that hold shares of Arbutus Biopharma Corp.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 01, 2023
Q3 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-3.5K- 12.12% |
$6.65K - $7.95K
|
25.4K
$89.4K
|
|
Nov 07, 2023
Q3 2023
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-3.98K- 9.05% |
$7.57K - $9.04K
|
40K
$141K
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-5.55K- 8.14% |
$10.5K - $12.6K
|
62.6K
$220K
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-8.97K- 52.19% |
$17K - $20.4K
|
8.21K
$28.9K
|
|
Nov 14, 2023
Q3 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-14K- 33.67% |
$26.6K - $31.7K
|
27.5K
$96.9K
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-17.5K- 7.87% |
$33.2K - $39.7K
|
205K
$720K
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-23.1K- 41.87% |
$43.9K - $52.5K
|
32.1K
$113K
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-36K- 58.71% |
$68.4K - $81.7K
|
25.3K
$89.1K
|
|
Nov 13, 2023
Q3 2023
|
Kepos Capital LP
New York, NY |
SELL
|
- |
-44.3K- 22.15% |
$84.2K - $101K
|
156K
$548K
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-47.9K- 2.17% |
$91K - $109K
|
2.16M
$7.61M
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-103K- 33.08% |
$196K - $234K
|
208K
$734K
|
|
Nov 01, 2023
Q3 2023
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-108K- 25.24% |
$205K - $245K
|
320K
$1.13M
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-279K- 12.15% |
$530K - $633K
|
2.02M
$7.1M
|